What are the current guidelines for the management of dengue?

Management of Dengue

Dengue management is primarily supportive care focused on early recognition of warning signs, judicious fluid resuscitation during the critical phase (days 3-7 of illness), and close monitoring to prevent complications from both plasma leakage and fluid overload 1, 2.

Clinical Classification and Risk Stratification

Dengue presents along a spectrum that requires systematic classification:

• Dengue without warning signs: Fever with 2+ of: nausea/vomiting, rash, aches/pains, positive tourniquet test, leukopenia
• Dengue with warning signs: Abdominal pain/tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy/restlessness, liver enlargement >2cm, rising hematocrit with rapid platelet drop
• Severe dengue: Severe plasma leakage (shock/fluid accumulation with respiratory distress), severe bleeding, or organ impairment (liver AST/ALT >1000, altered consciousness, heart/other organ involvement) 2, 3

The 2009 WHO classification captures more severe cases than the 1997 criteria (20% vs 5.5% in one validation study), improving sensitivity for identifying patients requiring intensive monitoring 4.

Diagnostic Approach

Timing determines test selection:

• ≤5 days from symptom onset: NS1 antigen detection or PCR/NAAT on serum 5, 6, 7
• 5-7 days: Either NS1 antigen or IgM antibody testing 5, 6
• >7 days: IgM antibody testing (ELISA) 5, 7
• Convalescent confirmation: IgG seroconversion at 3 weeks if needed 5

Critical caveat: Cross-reactivity occurs with other flaviviruses (Zika, yellow fever, Japanese encephalitis, West Nile). Document vaccination history and consider plaque reduction neutralization tests (PRNT) if definitive diagnosis is needed, though this is only available at reference laboratories 6, 7.

Fluid Management: The Cornerstone of Treatment

Outpatient Management (No Warning Signs)

• Oral rehydration with water, fruit juices, oral rehydration solution
• Avoid NSAIDs and aspirin (bleeding risk); use paracetamol/acetaminophen for fever
• Daily monitoring for warning signs during days 3-7 (critical phase)
• No prophylactic platelet transfusion 2

Hospitalization Criteria

Admit patients with:

• Any warning signs
• Evidence of plasma leakage (pleural effusion, ascites, rising hematocrit ≥20% from baseline)
• Severe dengue
• Comorbidities (pregnancy, infancy, elderly, diabetes, hypertension, chronic kidney/liver disease)
• Social factors preventing close outpatient monitoring 1, 2

Intravenous Fluid Resuscitation

For dengue with warning signs or compensated shock:

• First-line: Crystalloids (normal saline or Ringer's lactate) 2, 8
• Initial bolus: 5-7 mL/kg over 1-2 hours
• Reassess: If improved, reduce to 3-5 mL/kg/hour for 2-4 hours, then 2-3 mL/kg/hour
• Continue tapering based on clinical response (stable vital signs, adequate urine output >0.5 mL/kg/hour, declining hematocrit)
• Duration: Typically 24-48 hours of IV fluids 1, 8

For severe dengue shock syndrome:

• Crystalloids remain first-line in most cases 2
• Colloids may be considered in children with severe dengue shock (pulse pressure <10 mmHg) when crystalloids fail 9
• In moderate shock (pulse pressure 10-20 mmHg), crystalloids and colloids show similar outcomes; crystalloids preferred given lower cost and fewer adverse effects 9

Critical monitoring parameters:

• Vital signs every 1-4 hours depending on severity
• Hematocrit every 4-6 hours (rising indicates ongoing plasma leakage; falling suggests bleeding or hemodilution)
• Urine output hourly in severe cases
• Watch for fluid overload: respiratory distress, increasing oxygen requirement, rapidly rising jugular venous pressure 1, 2, 8

Transfusion Management

Platelet transfusion is NOT prophylactic 2. Transfuse only when:

• Active bleeding with thrombocytopenia
• Platelet count <10,000/μL with high bleeding risk
• Planned invasive procedure with platelet count <50,000/μL 2, 10

For significant bleeding: Fresh frozen plasma, packed red blood cells as clinically indicated 2, 8.

Complications Requiring Specific Management

Secondary Hemophagocytic Lymphohistiocytosis (HLH)

• Potentially fatal complication requiring high index of suspicion
• Consider in patients with persistent fever, cytopenias, hepatosplenomegaly, hyperferritinemia
• Treatment: Steroids or IVIG may improve outcomes 2
• This represents one of the few scenarios where immunomodulation has a role

Organ Involvement

• Hepatitis: Supportive care, avoid hepatotoxic drugs
• Encephalopathy: Exclude hypoglycemia, electrolyte disturbances, cerebral edema
• Myocarditis: Cardiac monitoring, inotropic support if needed
• Acute kidney injury: Fluid balance optimization, avoid nephrotoxins 2, 8

Discharge Criteria

Safe to discharge when ALL present:

• Afebrile for 24-48 hours without antipyretics
• Clinical improvement (appetite returns, hemodynamically stable)
• Hematocrit stable without IV fluids
• Platelet count >50,000/μL and rising
• No respiratory distress
• At least 48 hours since resolution of shock 1, 11

What NOT to Do

• No corticosteroids or IVIG for routine dengue (including chikungunya co-infection) unless HLH suspected 2, 11
• No NSAIDs or aspirin (bleeding risk) 2
• No prophylactic antibiotics (viral illness) 2
• Avoid aggressive fluid resuscitation beyond clinical need—overhydration causes pulmonary edema and pleural effusions 1, 2, 8
• Do not rely on platelet count alone for clinical decisions; clinical bleeding and plasma leakage are more important 2

Infection Control

• Standard precautions in healthcare settings
• Vector precautions: Mosquito nets/screens for hospitalized patients during febrile period (first 5-7 days) to prevent transmission to Aedes mosquitoes 11
• Viremia typically lasts 4-6 days after symptom onset 6

Key Clinical Pitfalls

1. Missing the critical phase (days 3-7): This is when plasma leakage occurs and patients deteriorate despite defervescence. Maintain vigilance even as fever resolves 1, 2.

2. Over-resuscitation: More patients die from fluid overload than under-resuscitation in well-monitored settings. Taper fluids aggressively once perfusion improves 1, 2, 8.

3. Misinterpreting hematocrit: A rising hematocrit indicates hemoconcentration from plasma leakage (give fluids); a falling hematocrit may indicate bleeding or hemodilution from excessive fluids 2, 8.

4. Testing too early or too late: NS1/PCR negative after day 7; IgM negative before day 5. Repeat testing at appropriate intervals if clinical suspicion remains high 6, 7.

The evidence base, while including older guidelines from 2009 [5-5], is reinforced by recent systematic reviews and operational protocols from 2023-2026 1, 2, 3, 10, 11 that consistently emphasize the same core principles: early recognition, judicious fluids, close monitoring, and avoidance of unnecessary interventions.